Efficacy and safety of glucose control with Space GlucoseControl in the medical intensive care unit--an open clinical investigation.

BACKGROUND We aimed to investigate the performance of the Space GlucoseControl system (SGC) (B. Braun, Melsungen, Germany) in medical critically ill patients. The SGC is a nurse-driven, computer-assisted device for glycemic control combining infusion pumps with the enhanced Model Predictive Control algorithm. SUBJECTS AND METHODS The trial was designed as a single-center, open clinical investigation in a nine-bed medical intensive care unit in a tertiary center in Graz, Austria. Efficacy was assessed by percentage of time within the target range (4.4-8.3 mmol/L; primary end point), mean blood glucose, and sampling interval. Safety was assessed by the number of hypoglycemic episodes (≤2.2 mmol/L). RESULTS Twenty mechanically ventilated patients (age, 63±16 years; body mass index, 31.0±10.7 kg/m(2); Acute Physiology and Chronic Health Evaluation II score, 25.4±6.3; 14 males; six with diabetes) were included for a period of 7.0±3.6 days. Time within target range was 83.4±8.9% (mean±SD), and mean arterial blood glucose was 6.8±0.4 mmol/L. No severe hypoglycemic episodes (<2.2 mmol/L) occurred, and the percentage of time within 2.2 and 3.3 mmol/L was low (0.03±0.07%). The sampling interval was 2.0±0.4 h. The mean insulin dose was 93.5±80.1 IU/day, and the adherence to the given insulin dose advice was high (98.3%). A total of 11 unintended therapy interruptions (0.08 events/treatment day) caused by software problems occurred in four patients. CONCLUSIONS SGC is a safe and efficient method to control blood glucose in critically ill patients in the medical intensive care unit.

[1]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[2]  Roman Hovorka,et al.  Closing the loop: the adicol experience. , 2004, Diabetes technology & therapeutics.

[3]  Marcus J Schultz,et al.  Predisposing factors for hypoglycemia in the intensive care unit* , 2006, Critical care medicine.

[4]  Roman Hovorka,et al.  Multicentric, randomized, controlled trial to evaluate blood glucose control by the model predictive control algorithm versus routine glucose management protocols in intensive care unit patients. , 2006, Diabetes care.

[5]  M. Levy,et al.  Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 , 2007, Intensive Care Medicine.

[6]  Roman Hovorka,et al.  Blood glucose control by a model predictive control algorithm with variable sampling rate versus a routine glucose management protocol in cardiac surgery patients: a randomized controlled trial. , 2007, The Journal of clinical endocrinology and metabolism.

[7]  R. Hovorka,et al.  Evaluation of Implementation of a Fully Automated Algorithm (Enhanced Model Predictive Control) in an Interacting Infusion Pump System for Establishment of Tight Glycemic Control in Medical Intensive Care Unit Patients , 2008, Journal of diabetes science and technology.

[8]  Malgorzata E. Wilinska,et al.  Tight glycaemic control by an automated algorithm with time-variant sampling in medical ICU patients , 2008, Intensive Care Medicine.

[9]  Malgorzata E. Wilinska,et al.  Intensive insulin therapy: enhanced Model Predictive Control algorithm versus standard care , 2008, Intensive Care Medicine.

[10]  S. V. Cromphaut,et al.  Hyperglycaemia as part of the stress response: the underlying mechanisms. , 2009 .

[11]  Evgeny Verbitskiy,et al.  Health technology assessment review: Computerized glucose regulation in the intensive care unit - how to create artificial control , 2009, Critical care.

[12]  Deborah J. Cook,et al.  Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data , 2009, Canadian Medical Association Journal.

[13]  R. Hovorka,et al.  Comparison of Three Protocols for Tight Glycemic Control in Cardiac Surgery Patients , 2009, Diabetes Care.

[14]  Stephane Heritier,et al.  Intensive versus conventional glucose control in critically ill patients. , 2009, The New England journal of medicine.

[15]  G. Amerongen,et al.  A plethora of angiopoietin-2 effects during clinical sepsis , 2010, Critical care.

[16]  V. Basevi.  Standards of Medical Care in Diabetes—2010 , 2010, Diabetes Care.

[17]  Roman Hovorka,et al.  Hospital glucose control: safe and reliable glycemic control using enhanced model predictive control algorithm in medical intensive care unit patients. , 2010, Diabetes technology & therapeutics.

[18]  E. Moghissi.  Reexamining the evidence for inpatient glucose control: new recommendations for glycemic targets. , 2010, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[19]  J. Krinsley.  Understanding Glycemic Control in the Critically Ill: 2011 Update , 2011, Hospital practice.

[20]  C. Mélot,et al.  Mild hypoglycemia is independently associated with increased mortality in the critically ill , 2011, Critical care.

[21]  P. Shekelle,et al.  Use of Intensive Insulin Therapy for the Management of Glycemic Control in Hospitalized Patients: A Clinical Practice Guideline From the American College of Physicians , 2011, Annals of Internal Medicine.